0.2250
0.0000
(0.00%)
At close: January 10 at 3:58:52 PM EST
Breakdown
TTM
10/31/2024
10/31/2023
10/31/2022
10/31/2021
Operating Expense
31,663.7420
31,663.7420
40,501.5930
24,753.7610
6,936.5070
Operating Income
-31,663.7420
-31,663.7420
-40,501.5930
-24,753.7610
-6,936.5070
Net Non Operating Interest Income Expense
-198.4670
-198.4670
1,468.1470
459.2830
12.1840
Other Income Expense
-322.9260
-322.9260
35.9260
-126.0580
-41.2160
Pretax Income
-32,185.1350
-32,185.1350
-38,997.5200
-24,420.5360
-6,965.5390
Tax Provision
7.0000
7.0000
--
--
--
Net Income Common Stockholders
-32,192.1350
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Diluted NI Available to Com Stockholders
-32,192.1350
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Basic EPS
-0.10
--
-0.13
-0.09
-0.03
Diluted EPS
-0.10
--
-0.13
-0.09
-0.03
Basic Average Shares
306,954.3300
--
303,332.6860
273,593.1430
245,522.7700
Diluted Average Shares
306,954.3300
--
303,332.6860
273,593.1430
245,522.7700
Total Expenses
31,663.7420
31,663.7420
40,501.5930
24,753.7610
6,936.5070
Net Income from Continuing & Discontinued Operation
-32,192.1350
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Normalized Income
-31,917.6479
-31,917.6479
-39,033.4460
-24,294.4780
-6,924.3230
Interest Income
388.3910
388.3910
1,500.2220
577.2850
70.5520
Interest Expense
586.8580
586.8580
32.0750
118.0020
58.3680
Net Interest Income
-198.4670
-198.4670
1,468.1470
459.2830
12.1840
EBIT
-31,598.2770
-31,598.2770
-38,965.4450
-24,302.5340
-6,907.1710
EBITDA
-31,057.9970
-31,057.9970
-38,519.8940
-23,862.5360
-6,639.9670
Reconciled Depreciation
540.2800
540.2800
445.5510
439.9980
267.2040
Net Income from Continuing Operation Net Minority Interest
-32,192.1350
-32,192.1350
-38,997.5200
-24,420.5360
-6,965.5390
Total Unusual Items Excluding Goodwill
-322.9260
-322.9260
35.9260
-126.0580
-41.2160
Total Unusual Items
-322.9260
-322.9260
35.9260
-126.0580
-41.2160
Normalized EBITDA
-30,735.0710
-30,735.0710
-38,555.8200
-23,736.4780
-6,598.7510
Tax Rate for Calcs
0.0002
0.0002
--
--
--
Tax Effect of Unusual Items
-48.4389
-48.4389
--
--
--
10/31/2021 - 4/29/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XRTX XORTX Therapeutics Inc.
1.2600
-3.08%
XRTX.V XORTX Therapeutics Inc.
1.8500
-5.13%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
MBIO.CN MindBio Therapeutics Corp.
0.0200
0.00%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
NGEN.V NervGen Pharma Corp.
3.0900
+3.69%